A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
NCT ID: NCT00002369
Last Updated: 2007-10-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
200 participants
INTERVENTIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients will be treated for 48 weeks.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PARALLEL
TREATMENT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Indinavir sulfate
Lamivudine
Stavudine
Zidovudine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Documented HIV infection.
* CD4 cell count of 200 - 700 cells/mm3.
Exclusion Criteria
Patients with the following symptoms or conditions are excluded:
AIDS defining condition within 1 month of study entry.
Prior Medication:
Excluded:
Patients with any history of antiretroviral therapy treatment.
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bristol-Myers Squibb
INDUSTRY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Univ of Alabama at Birmingham
Birmingham, Alabama, United States
HIV Clinical Research Ctr
Fort Lauderdale, Florida, United States
Infectious Disease Research Institute Inc
Tampa, Florida, United States
Advance Clinical Research
Atlanta, Georgia, United States
Louisiana State Univ Med Ctr / HIV Outpatient Clinic
New Orleans, Louisiana, United States
Boston Univ Med Ctr Hosp / Evans - 556
Boston, Massachusetts, United States
Community Research Initiative of New England
Brookline, Massachusetts, United States
Washington Univ School of Medicine
St Louis, Missouri, United States
Blackstock Family Health Ctr
Austin, Texas, United States
Hosp Regional de Ponce - Area Vieja
Ponce, , Puerto Rico
San Juan AIDS Program
Santurce, , Puerto Rico
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BMS 001
Identifier Type: -
Identifier Source: secondary_id
260A
Identifier Type: -
Identifier Source: org_study_id